Tuesday, December 17, 2024
HomeTagsNeoPhore

NeoPhore

NeoPhore appoints Michael Shih as Chief Executive Officer

NeoPhore Limited, a small molecule neoantigen immuno-oncology company, announces the appointment of Michael Shih as Chief Executive Officer (CEO) and to the Board of Directors, effective...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics